Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Langley

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|April 25, 2009
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditionsSama F Sleiman, Manuela Basso, Lata Mahishi, et al.
Developmental Biology|June 25, 2005
Proteolytic processing of myostatin is auto-regulated during myogenesisCraig McFarlane, Brett Langley, Mark Thomas, et al.
ACS Medicinal Chemistry Letters|December 1, 2015
Thiol-Based Potent and Selective HDAC6 Inhibitors Promote Tubulin Acetylation and T-Regulatory Cell Suppressive FunctionMariana C F Segretti, Gian Paolo Vallerini, Camille Brochier, et al.
Neurobiology of Disease|September 5, 2012
A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor propertiesThong C Ma, Brett Langley, Brian Ko, et al.
Chemmedchem|April 28, 2009
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stressAlan P Kozikowski, Yihua Chen, Tapadar Subhasish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2008
Epigenetics in the nervous systemYan Jiang, Brett Langley, Farah D Lubin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 4, 2008
Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotectionBrett Langley, Melissa A D'Annibale, Kyungsun Suh, et al.
The Journal of Biological Chemistry|October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's diseaseGabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2009
HDAC6 is a target for protection and regeneration following injury in the nervous systemMark A Rivieccio, Camille Brochier, Dianna E Willis, et al.
Experimental Neurology|March 10, 2020
HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in miceCristina Picci, Victor S C Wong, Christopher J Costa, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|April 25, 2009
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditionsSama F Sleiman, Manuela Basso, Lata Mahishi, et al.
Developmental Biology|June 25, 2005
Proteolytic processing of myostatin is auto-regulated during myogenesisCraig McFarlane, Brett Langley, Mark Thomas, et al.
ACS Medicinal Chemistry Letters|December 1, 2015
Thiol-Based Potent and Selective HDAC6 Inhibitors Promote Tubulin Acetylation and T-Regulatory Cell Suppressive FunctionMariana C F Segretti, Gian Paolo Vallerini, Camille Brochier, et al.
Neurobiology of Disease|September 5, 2012
A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor propertiesThong C Ma, Brett Langley, Brian Ko, et al.
Chemmedchem|April 28, 2009
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stressAlan P Kozikowski, Yihua Chen, Tapadar Subhasish, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 14, 2008
Epigenetics in the nervous systemYan Jiang, Brett Langley, Farah D Lubin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 4, 2008
Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotectionBrett Langley, Melissa A D'Annibale, Kyungsun Suh, et al.
The Journal of Biological Chemistry|October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's diseaseGabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2009
HDAC6 is a target for protection and regeneration following injury in the nervous systemMark A Rivieccio, Camille Brochier, Dianna E Willis, et al.
Experimental Neurology|March 10, 2020
HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in miceCristina Picci, Victor S C Wong, Christopher J Costa, et al.
Pageof 4